LON:EKF - Ekf Diagnostics Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Ekf Diagnostics Holding PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 35.50 +0.85 (+2.45 %) (As of 02/23/2020 04:00 PM ET) Add Compare Today's Range 34.40Now: GBX 35.50▼ 36.6050-Day Range 32.25MA: GBX 33.14▼ 35.8052-Week Range 29Now: GBX 35.50▼ 37.96Volume368,288 shsAverage Volume206,806 shsMarket Capitalization£161.20 millionP/E Ratio15.43Dividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Africa, and internationally. It offers DiaSpect Tm, an hemoglobin analyzer; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a point-of-care hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a centrifuge that provides a hematocrit reading for six blood samples. Read More… Industry, Sector and Symbol Stock Exchange LON Industry Medical Appliances & Equipment Sub-IndustryN/A SectorMedical Current SymbolLON:EKF Previous Symbol CUSIPN/A CIKN/A Webhttp://www.ekfdiagnostics.com/ Phone+44-29-20710570Debt Debt-to-Equity Ratio2.67 Current Ratio1.81 Quick Ratio1.34Price-To-Earnings Trailing P/E Ratio15.43 Forward P/E Ratio0.44 P/E GrowthN/A Sales & Book Value Annual Sales£43.62 million Price / Sales3.70 Cash FlowGBX 2.97 per share Price / Cash Flow11.96 Book ValueGBX 14.60 per share Price / Book2.43Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares454,092,992Market Cap£161.20 million Next Earnings DateN/A OptionableNot Optionable Receive EKF News and Ratings via Email Sign-up to receive the latest news and ratings for EKF and its competitors with MarketBeat's FREE daily newsletter. LSE:EKF Rates by TradingView Ekf Diagnostics (LON:EKF) Frequently Asked Questions What is Ekf Diagnostics' stock symbol? Ekf Diagnostics trades on the London Stock Exchange (LON) under the ticker symbol "EKF." Has Ekf Diagnostics been receiving favorable news coverage? Media coverage about EKF stock has trended very negative on Sunday, according to InfoTrie. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Ekf Diagnostics earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the next few days. View News Stories for Ekf Diagnostics. Who are some of Ekf Diagnostics' key competitors? Some companies that are related to Ekf Diagnostics include Consort Medical (CSRT), Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), Intelligent Ultrasound Group (MED), LiDCO Group (LID), Deltex Medical Group (DEMG), InspireMD (NSPR), Zecotek Photonics (ZMS), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS). What other stocks do shareholders of Ekf Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ekf Diagnostics investors own include ERBA Diagnostics (ERBA), Telford Homes (TEF), Kirkland Lake Gold (KLG), ASOS (ASC), Advanced Computer Software Group (asw), Boohoo Group (BOO), SolGold (SOLG), Newmont Goldcorp (NEM), Avesoro Resources (ASO) and Arcontech Group (ARC). Who are Ekf Diagnostics' key executives? Ekf Diagnostics' management team includes the folowing people: Mr. Julian Huw Baines, CEO & Exec. Director (Age 54)Mr. Richard Anthony Evans, COO, Fin. Director & Exec. Director (Age 62)Mr. Andrew Webb, Chief Exec. Officer of Ekf MolecularSalim Hamir, Company Sec. How do I buy shares of Ekf Diagnostics? Shares of EKF and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Ekf Diagnostics' stock price today? One share of EKF stock can currently be purchased for approximately GBX 35.50. How big of a company is Ekf Diagnostics? Ekf Diagnostics has a market capitalization of £161.20 million and generates £43.62 million in revenue each year. View Additional Information About Ekf Diagnostics. What is Ekf Diagnostics' official website? The official website for Ekf Diagnostics is http://www.ekfdiagnostics.com/. How can I contact Ekf Diagnostics? Ekf Diagnostics' mailing address is Avon HSE, 19 Stanwell Road, PENARTH, CF64 2EZ, United Kingdom. The company can be reached via phone at +44-29-20710570. MarketBeat Community Rating for Ekf Diagnostics (LON EKF)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 323 (Vote Outperform)Underperform Votes: 195 (Vote Underperform)Total Votes: 518MarketBeat's community ratings are surveys of what our community members think about Ekf Diagnostics and other stocks. Vote "Outperform" if you believe EKF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EKF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2020 by MarketBeat.com StaffFeatured Article: How to Invest in an Index Fund
